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Symptoms of hyperandrogenism and virilization in postmenopausal women warrant workup for ovarian hyperthecosis. In this
case series, we discuss two patients who presented with symptoms of hyperandrogenism and metabolic abnormalities including
insulin resistance stemming from ovarian hyperthecosis. Imaging revealed normal ovaries in both patients. However, both
patients had total serum testosterone levels below the lower diagnostic limit for ovarian hyperthecosis. Due to high clinical
suspicion of ovarian hyperthecosis, both patients underwent bilateral oophorectomy without venous sampling for ovarian
androgens. The diagnosis of ovarian hyperthecosis was conﬁrmed on histological examination. Both women had improvement in
their hyperandrogenic symptoms, testosterone levels, and biochemical features of insulin resistance after surgical intervention.
This presentation of ovarian hyperthecosis with subdiagnostic total serum testosterone levels demonstrates the need for continued
research into the pathophysiology of the disease, discussion of the diagnostic threshold of total serum testosterone, as well as the
inclusion of ovarian hyperthecosis in the diﬀerential of postmenopausal women with hyperandrogenism and insulin resistance.

1. Introduction

2. Case Presentation

Ovarian hyperthecosis refers to a process in which ovarian cells
diﬀerentiate into clusters of luteinized thecal cells in the ovarian
stroma producing excessive amounts of testosterone. This
condition commonly presents in postmenopausal women with
symptoms similar to that of polycystic ovarian syndrome [1].
The disorder can result in metabolic abnormalities such as
insulin resistance which can then lead to hyperinsulinemia.
Hyperinsulinemia can result in an increased risk for type 2
diabetes mellitus and cardiovascular disease [2]. Acne and
hirsutism secondary to high testosterone levels are also commonly present [3]. In this article, we discuss two patients with
symptomatic ovarian hyperthecosis and laboratory levels below
the standard diagnostic criteria. The discussed cases highlight
the importance of using clinical impression and metabolic
symptomology to conﬁrm the diagnosis of ovarian hyperthecosis, although testosterone levels may be below the usual
diagnostic threshold for the disease [4].

2.1. Case 1. A 60-year-old female with a history of dyslipidemia, hypertension, polycystic ovarian syndrome, and
obstructive sleep apnea was referred to endocrinology for
management of severe hirsutism, fatty liver disease, hyperlipidemia, and type 2 diabetes mellitus. She reported a
longstanding history of hirsutism with frontal balding that
progressed over ﬁve years and was being treated with spironolactone. She described her libido as normal and denied
any clitoromegaly or acne. Compared to one year prior,
laboratory results revealed mild elevations in ALT (increasing from 34 to 52) and AST (increasing from 34 to 43).
Additionally, hemoglobin A1c (HbA1c) increased from
6.7% to 8.0%. Total serum testosterone levels were at 145 ng/
dL.
The patient was started on metformin 2000 mg and
subcutaneous semaglutide 0.5 mg to manage her diabetes.
Due to her abnormal liver enzyme levels, she was screened
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for chronic hepatitis which was negative. Pelvic ultrasound
revealed a 2.5 cm simple cyst within the right ovary and an
incidental 9 mm calciﬁcation within the endometrial canal.
Her gonadotropin levels were below normal for her postmenopausal state, and DHEA-S, 17-hydroxyprogesterone,
and prolactin levels were normal. She was referred to an
obstetrician-gynecologist due to suspicion of ovarian
hyperthecosis. No adrenal/ovarian vein sampling was performed as it was not available at the facility.
After discussion with the patient and the gynecological
team, it was decided that a complete hysterectomy was a
reasonable option due to the high suspicion of ovarian
hyperthecosis and the presence of rectocele and cystocele.
Posthysterectomy, the pathology report was remarkable for
atrophic endometrium and bilateral ovarian hyperthecosis
as shown in Figure 1. Labs collected during the one-month
posthysterectomy follow-up visit were signiﬁcant, in which
liver transaminase levels had returned to normal and HbA1c
had improved to 6.3%. Additionally, total serum testosterone decreased to 7 ng/dL, and the patient noted that her
hirsutism had mildly improved.
2.2. Case 2. A 58-year-old female with a history of hysterectomy in 1999 and hyperlipidemia was referred to endocrinology for management of type 2 diabetes mellitus and
hirsutism. She noted excessive hair growth for the past three
years which required her to shave and pluck her facial hair
daily. She also complained of worsening acne, folliculitis,
clitoromegaly, and occasional light vaginal bleeding. She described her libido as normal. She voiced concerns about a rising
HbA1c increasing from normal to 8.2% over a six-month
period. Additional laboratory tests showed a normal TSH at
3.38 uU/mL and elevated total serum testosterone of 135 ng/dL.
The patient was started on metformin 2000 mg for
management of her diabetes. The patient’s rapid progression
of diabetes and recent development of hirsutism was worrisome for insulin resistance in the setting of an underlying
etiology such as high testosterone levels. Pelvic ultrasound
showed normal bilateral ovaries containing small cysts or
follicles. Pelvic MRI demonstrated bilateral ovarian enlargement for the patient’s age, which was more pronounced
in the right ovary than the left ovary. Additional laboratory
testing revealed normal prolactin, 17-hydroxyprogesterone,
and androstenedione levels. However, the patient had
subnormal age-speciﬁc LH and FSH levels. Based on the
imaging and laboratory results, the patient was referred to
the gynecological team. The patient then underwent bilateral
oophorectomy due to a high suspicion of ovarian
hyperthecosis.
The oophorectomy pathology report was signiﬁcant for
bilateral ovarian hyperthecosis as shown in Figure 2. Laboratory results collected one-month postoophorectomy
demonstrated an improvement in HbA1c from 8.2% to 6.1%
and testosterone from 135 ng/dL to 16 ng/dL. The patient
denied signiﬁcant improvement in hirsutism after the surgery and stated that she continued to have excess hair on the
abdomen and bilateral upper extremities. However, she
reported signiﬁcant improvement in clitoromegaly.
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3. Discussion
These cases emphasize the importance of including ovarian
hyperthecosis in the diﬀerential diagnosis when a postmenopausal woman presents with hirsutism, symptoms of
virilization, or symptoms of rapidly progressive insulin
resistance (in the absence of clinical or biochemical abnormalities of other etiologies such as Cushing’s syndrome
or hypothyroidism). Current guidelines recommend that
ovarian hyperthecosis is less likely if total serum testosterone
levels are below 150 ng/dL [4]. As described in the cases,
both patients had a total serum testosterone level below
150 ng/dL and were still diagnosed with ovarian hyperthecosis and had signiﬁcant improvement in symptoms
postoophorectomy. In patients with symptoms of severe
hyperandrogenism, it is important to rule out androgensecreting ovarian and adrenal tumors. In the cases discussed,
adrenal tumors were lower on the diﬀerential due to normal
adrenal androgen levels. A gonadotropin secreting pituitary
adenoma was also unlikely given that the patients did not
have any suggestive symptoms or laboratory ﬁndings consistent with adenoma. Congenital adrenal hyperplasia was
additionally ruled out due to normal 17-hydroxyprogesterone levels. Exposure to synthetic androgens was
also ruled out due to normal androstenedione levels and
patient denial of exogenous hormone intake. Both patients
had a signiﬁcant improvement in their hemoglobin A1C as
well as their total serum testosterone levels after oophorectomy as given in Table 1.
In the workup of patients presenting with elevated total
serum testosterone levels and virilization, the ﬁrst step is to
identify the source of the excess androgen production. Pelvic
ultrasound in women with hyperthecosis is recommended to
rule out androgen-producing tumors and usually shows a
bilateral increase in ovarian size and stroma [5]. If imaging is
negative and a strong suspicion of ovarian hyperthecosis
remains, the next step is to perform ovarian venous sampling. It is important to note, however, that ovarian venous
sampling is an advanced procedure requiring technical
expertise, and evidence for using it in clinical practice is not
substantiated [6, 7]. Additionally, the procedure is not offered at all facilities.
Insulin resistance is a key component in identifying
ovarian hyperthecosis [8]. It is important to measure sex
hormone-binding globulin (SHBG) levels as low levels can
serve as a predictive marker for insulin resistance when
underlying hyperandrogenism is a suspected cause [9]. Once
hyperthecosis is suspected, it is vital to address and manage
the various complications caused by increased androgen
levels. Patients should be counseled on weight control,
lifestyle modiﬁcations, and started on metformin for better
glycemic control if HbA1c is elevated [10]. The deﬁnitive
treatment for patients with hyperthecosis is bilateral oophorectomy, and diagnosis of hyperthecosis is conﬁrmed
only by histological analysis. If patients are unable to tolerate
surgery, treatment with a long-term gonadotropin-releasing
hormone agonist is recommended to suppress the HPG axis.
Currently, a surgical approach is preferred for the management of hyperthecosis over medical management [3, 11].
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Figure 1: Microscopic images depict ovarian hyperthecosis with stromal hyperplasia and abundant spindled theca cells. Corpora albicantia
(B) was also apparent throughout the specimen. Hematoxylin and eosin stain, original magniﬁcation: (a) 4x, (b) 4x, (c) 20x, and (d) 40x.

(b)
(a)

Figure 2: Continued.
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Figure 2: Microscopic images depicting ovarian hyperthecosis with stromal hyperplasia and abundant spindled theca cells. Corpora
albicantia (B) was also apparent throughout the specimen. Hematoxylin and eosin stain, original magniﬁcation: (a) 4x, (b) 4x, (c) 20x, and
(d) 40x.

Table 1: Pre and postbilateral oophorectomy laboratory results for case 1 and case 2.

Labs
HbA1c (%)
Serum testosterone (ng/dL)
LH (IU/L)
FSH (IU/L)
DHEA-S (mcg/dL)
17-Hydroxyprogesterone (ng/dL)
Prolactin (ng/mL)
Hb (g/dL)
Hct (%)

Case 1: pre and postsurgery lab
results
Presurgery
Postsurgery
8
6.3
145
7
15.9
N/A
20.9
24.4
25
72
8.8
14.0
12.7
42.3
41.0

Case 2: pre and postsurgery lab
results
Presurgery
Postsurgery
8.2
6.1
135
16
21.2
49.9
31.5
74.1
47
195
7.9
14.7
14.8
45.5
46.2

4. Conclusion

Data Availability

In postmenopausal patients presenting with symptoms of
hyperandrogenism, it is important to evaluate for malignant
androgen-producing ovarian or adrenal tumors, congenital
adrenal hyperplasia, and Cushing’s disease. While the testosterone levels in patients discussed were not markedly
elevated, the clinical picture was suggestive of ovarian
hyperthecosis. After reviewing the patient history, physical
exam ﬁndings, imaging, and laboratory results, the diagnosis
of hyperthecosis was at the top of the diﬀerential. Postoophorectomy, both patients showed remarkable improvement in HbA1c and serum testosterone levels.
Interestingly, the identiﬁcation and diagnosis of ovarian
hyperthecosis in the presented cases involved testosterone
levels below the recommended diagnostic threshold. The
discussed cases show that there is a need for continued
research and a further discussion into the diagnostic
guidelines to better understand the pathophysiology of this
disease including the clinical presentation and biochemical
ﬁndings.

No data were used to support this study.
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